Skip to content
lifestyle.hubspotes.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
AKAMPION
EktaH Advances First-in-Class Obesity Treatment NKS-3 into Phase II Clinical Development
November 16, 2026
New Kidney International Study Provides Preclinical Proof-of-Concept for TolerogenixX’s MIC Platform in Lupus Nephritis
November 11, 2026
Peer-Reviewed Publication in Clinical & Experimental Allergy Reveals Potential Disease-Modifying Effect of Mabylon’s Allergen-Neutralizing Antibodies
November 3, 2026
1ST Biotherapeutics and SK Biopharmaceuticals Announce Exclusive Global License Agreement for Parkinson’s Disease Candidate ‘1ST-104’
September 17, 2026
TolerogenixX Has Received EMA Orphan Drug Designation for MIC-Lx, Strengthening its Regulatory Pathway in Kidney Transplantation
July 13, 2026
Omnix Medical Launches New Horizon Europe PEPTAMR Infectious Disease Consortium
July 13, 2026
TolerogenixX Completes Last Patient Transplant in Phase IIb TOL-2 Trial of MIC-Lx, Advancing a New Immune Tolerance Approach in Kidney Transplantation
June 29, 2026